1. Home
  2. CTLT

CTLT

Catalent Inc.

Logo Catalent Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 3:30pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

Founded: 2007 Country:
United States
United States
Employees: N/A City: SOMERSET
Market Cap: 10.0B IPO Year: 2014
Target Price: $52.04 AVG Volume (30 days): 2.8M
Analyst Decision: Hold Number of Analysts: 13
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -7.19 EPS Growth: N/A
52 Week Low/High: $31.45 - $60.20 Next Earning Date: 05-07-2024
Revenue: $4,098,000,000 Revenue Growth: -13.38%
Revenue Growth (this year): 4.55% Revenue Growth (next year): 6.98%

Share on Social Networks: